PLRZ earnings date and last-quarter result: P/E -4.12. Updated 2026-07-23.
Polyrizon (PLRZ) Research Hub
Polyrizon (PLRZ) trades on NASDAQ, IL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 8.96 USD (+2.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.12, market cap 0.02B. This hub links to the full technical, earnings and options research available for PLRZ.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 8.96 USD (+2.69%) |
| 52-week range | 8 USD – 15.91 USD |
| Trend regime | Range |
| 14-day RSI | 41.9 (Bearish) |
| Trailing P/E | -4.12 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for PLRZ
Covered Call on PLRZ: how it works, illustrative setup around the real 8.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PLRZ: how it works, illustrative setup around the real 8.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PLRZ: how it works, illustrative setup around the real 8.96 USD price, max profit/loss, breakeven and when to use it. Educational.
PLRZ technical analysis: range, last 8.96 USD, RSI 41.9, 52w range 8 USD–15.91 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PLRZ in?
Polyrizon (PLRZ) is classified under Healthcare (Biotechnology), listed on NASDAQ, IL.
Is PLRZ in an uptrend or downtrend?
As of 2026-10-26, PLRZ is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PLRZ's trailing P/E ratio?
PLRZ's trailing P/E is -4.12, with a market cap of 0.02B. See the earnings research page for full valuation detail.